Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2020
Equine rabies immunoglobulin (ERIG) cheaper than human rabies immune globulin (HRIG), so for patients in developing countries (such as India), and prices are more affordable.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Equine Rabies Immunoglobulin (ERIG) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Equine Rabies Immunoglobulin (ERIG) industry.
Based on our recent survey, we have several different scenarios about the Equine Rabies Immunoglobulin (ERIG) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Equine Rabies Immunoglobulin (ERIG) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research has recently curated a research report titled, Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2020. The report is structured on primary and secondary research methodologies that derive historic and forecast data. The global Equine Rabies Immunoglobulin (ERIG) market is growing remarkably fast and is likely to thrive in terms of volume and revenue during the forecast period. Readers can gain insight into the various opportunities and restraints shaping the market. The report demonstrates the progress and bends that will occur during the forecast period.
Global Equine Rabies Immunoglobulin (ERIG) Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Equine Rabies Immunoglobulin (ERIG) Market: Segment Analysis
The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Equine Rabies Immunoglobulin (ERIG) Market: Regional Analysis
The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Equine Rabies Immunoglobulin (ERIG) Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
Following are the segments covered by the report are:
The Key manufacturers that are operating in the global Equine Rabies Immunoglobulin (ERIG) market are:
The analysts have provided a comprehensive analysis of the competitive landscape of the global Equine Rabies Immunoglobulin (ERIG) market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Equine Rabies Immunoglobulin (ERIG) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Equine Rabies Immunoglobulin (ERIG) industry.
Based on our recent survey, we have several different scenarios about the Equine Rabies Immunoglobulin (ERIG) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Equine Rabies Immunoglobulin (ERIG) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research has recently curated a research report titled, Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2020. The report is structured on primary and secondary research methodologies that derive historic and forecast data. The global Equine Rabies Immunoglobulin (ERIG) market is growing remarkably fast and is likely to thrive in terms of volume and revenue during the forecast period. Readers can gain insight into the various opportunities and restraints shaping the market. The report demonstrates the progress and bends that will occur during the forecast period.
Global Equine Rabies Immunoglobulin (ERIG) Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of sales about the global market and also about each type from 2015 to 2026. This section mentions the volume of sales by region from 2015 to 2026. Pricing analysis is included in the report according to each type from the year 2015 to 2026, manufacturer from 2015 to 2020, region from 2015 to 2020, and global price from 2015 to 2026.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Equine Rabies Immunoglobulin (ERIG) Market: Segment Analysis
The research report includes specific segments such as application and product type. Each type provides information about the sales during the forecast period of 2015 to 2026. The application segment also provides revenue by volume and sales during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Equine Rabies Immunoglobulin (ERIG) Market: Regional Analysis
The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Equine Rabies Immunoglobulin (ERIG) Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
Following are the segments covered by the report are:
- 1500IU
- 1000IU
- 400IU
- Other
- Category II Exposure
- Category III Exposure
The Key manufacturers that are operating in the global Equine Rabies Immunoglobulin (ERIG) market are:
- Serum China
- Lanzhou Institute of Biological Products
- Wuhan Institute of Biological Products
- Premium Serums
- Haffkine Bio-Pharmaceutical
- Bharat Serums
- ...
The analysts have provided a comprehensive analysis of the competitive landscape of the global Equine Rabies Immunoglobulin (ERIG) market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.
1 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET OVERVIEW
1.1 Product Overview and Scope of Equine Rabies Immunoglobulin (ERIG)
1.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Equine Rabies Immunoglobulin (ERIG) Segment by Application
1.3.1 Equine Rabies Immunoglobulin (ERIG) Sales Comparison by Application: 2020 VS 2026
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Equine Rabies Immunoglobulin (ERIG) Market Size Estimates and Forecasts
1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue 2015-2026
1.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales 2015-2026
1.4.3 Equine Rabies Immunoglobulin (ERIG) Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Equine Rabies Immunoglobulin (ERIG) Industry Impact
1.5.1 How the Covid-19 is Affecting the Equine Rabies Immunoglobulin (ERIG) Industry
1.5.1.1 Equine Rabies Immunoglobulin (ERIG) Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Equine Rabies Immunoglobulin (ERIG) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Equine Rabies Immunoglobulin (ERIG) Players to Combat Covid-19 Impact
2 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET COMPETITION BY MANUFACTURERS
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2015-2020)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Equine Rabies Immunoglobulin (ERIG) Manufacturing Sites, Area Served, Product Type
2.5 Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation and Trends
2.5.1 Equine Rabies Immunoglobulin (ERIG) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Equine Rabies Immunoglobulin (ERIG) Players (Opinion Leaders)
3 EQUINE RABIES IMMUNOGLOBULIN (ERIG) RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.3.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.4.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.4.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Region
3.5.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region
3.5.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.6.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.6.2 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.7.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.7.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2015-2020)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2015-2020)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price Market Share by Type (2015-2020)
4.4 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2015-2020)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2015-2020)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN EQUINE RABIES IMMUNOGLOBULIN (ERIG) BUSINESS
6.1 Serum China
6.1.1 Corporation Information
6.1.2 Serum China Description, Business Overview and Total Revenue
6.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Serum China Products Offered
6.1.5 Serum China Recent Development
6.2 Lanzhou Institute of Biological Products
6.2.1 Lanzhou Institute of Biological Products Corporation Information
6.2.2 Lanzhou Institute of Biological Products Description, Business Overview and Total Revenue
6.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Lanzhou Institute of Biological Products Products Offered
6.2.5 Lanzhou Institute of Biological Products Recent Development
6.3 Wuhan Institute of Biological Products
6.3.1 Wuhan Institute of Biological Products Corporation Information
6.3.2 Wuhan Institute of Biological Products Description, Business Overview and Total Revenue
6.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Wuhan Institute of Biological Products Products Offered
6.3.5 Wuhan Institute of Biological Products Recent Development
6.4 Premium Serums
6.4.1 Premium Serums Corporation Information
6.4.2 Premium Serums Description, Business Overview and Total Revenue
6.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Premium Serums Products Offered
6.4.5 Premium Serums Recent Development
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description, Business Overview and Total Revenue
6.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Haffkine Bio-Pharmaceutical Products Offered
6.5.5 Haffkine Bio-Pharmaceutical Recent Development
6.6 Bharat Serums
6.6.1 Bharat Serums Corporation Information
6.6.2 Bharat Serums Description, Business Overview and Total Revenue
6.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bharat Serums Products Offered
6.6.5 Bharat Serums Recent Development
7 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MANUFACTURING COST ANALYSIS
7.1 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
7.4 Equine Rabies Immunoglobulin (ERIG) Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Equine Rabies Immunoglobulin (ERIG) Distributors List
8.3 Equine Rabies Immunoglobulin (ERIG) Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Type (2021-2026)
10.2 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Application (2021-2026)
10.3 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Region (2021-2026)
10.4 North America Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.5 Europe Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.6 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.7 Latin America Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
1.1 Product Overview and Scope of Equine Rabies Immunoglobulin (ERIG)
1.2 Equine Rabies Immunoglobulin (ERIG) Segment by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Equine Rabies Immunoglobulin (ERIG) Segment by Application
1.3.1 Equine Rabies Immunoglobulin (ERIG) Sales Comparison by Application: 2020 VS 2026
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Equine Rabies Immunoglobulin (ERIG) Market Size Estimates and Forecasts
1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue 2015-2026
1.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales 2015-2026
1.4.3 Equine Rabies Immunoglobulin (ERIG) Market Size by Region: 2020 Versus 2026
1.5 Coronavirus Disease 2019 (Covid-19): Equine Rabies Immunoglobulin (ERIG) Industry Impact
1.5.1 How the Covid-19 is Affecting the Equine Rabies Immunoglobulin (ERIG) Industry
1.5.1.1 Equine Rabies Immunoglobulin (ERIG) Business Impact Assessment - Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Equine Rabies Immunoglobulin (ERIG) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Equine Rabies Immunoglobulin (ERIG) Players to Combat Covid-19 Impact
2 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) MARKET COMPETITION BY MANUFACTURERS
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2015-2020)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Equine Rabies Immunoglobulin (ERIG) Manufacturing Sites, Area Served, Product Type
2.5 Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation and Trends
2.5.1 Equine Rabies Immunoglobulin (ERIG) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Equine Rabies Immunoglobulin (ERIG) Players (Opinion Leaders)
3 EQUINE RABIES IMMUNOGLOBULIN (ERIG) RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Equine Rabies Immunoglobulin (ERIG) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.3.1 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.3.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.4.1 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.4.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Region
3.5.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region
3.5.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.6.1 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.6.2 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.7.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.7.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2015-2020)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2015-2020)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price Market Share by Type (2015-2020)
4.4 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 GLOBAL EQUINE RABIES IMMUNOGLOBULIN (ERIG) HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2015-2020)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2015-2020)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN EQUINE RABIES IMMUNOGLOBULIN (ERIG) BUSINESS
6.1 Serum China
6.1.1 Corporation Information
6.1.2 Serum China Description, Business Overview and Total Revenue
6.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Serum China Products Offered
6.1.5 Serum China Recent Development
6.2 Lanzhou Institute of Biological Products
6.2.1 Lanzhou Institute of Biological Products Corporation Information
6.2.2 Lanzhou Institute of Biological Products Description, Business Overview and Total Revenue
6.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Lanzhou Institute of Biological Products Products Offered
6.2.5 Lanzhou Institute of Biological Products Recent Development
6.3 Wuhan Institute of Biological Products
6.3.1 Wuhan Institute of Biological Products Corporation Information
6.3.2 Wuhan Institute of Biological Products Description, Business Overview and Total Revenue
6.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Wuhan Institute of Biological Products Products Offered
6.3.5 Wuhan Institute of Biological Products Recent Development
6.4 Premium Serums
6.4.1 Premium Serums Corporation Information
6.4.2 Premium Serums Description, Business Overview and Total Revenue
6.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Premium Serums Products Offered
6.4.5 Premium Serums Recent Development
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description, Business Overview and Total Revenue
6.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Haffkine Bio-Pharmaceutical Products Offered
6.5.5 Haffkine Bio-Pharmaceutical Recent Development
6.6 Bharat Serums
6.6.1 Bharat Serums Corporation Information
6.6.2 Bharat Serums Description, Business Overview and Total Revenue
6.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bharat Serums Products Offered
6.6.5 Bharat Serums Recent Development
7 EQUINE RABIES IMMUNOGLOBULIN (ERIG) MANUFACTURING COST ANALYSIS
7.1 Equine Rabies Immunoglobulin (ERIG) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
7.4 Equine Rabies Immunoglobulin (ERIG) Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Equine Rabies Immunoglobulin (ERIG) Distributors List
8.3 Equine Rabies Immunoglobulin (ERIG) Customers
9 MARKET DYNAMICS
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Global Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Type (2021-2026)
10.2 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Application (2021-2026)
10.3 Equine Rabies Immunoglobulin (ERIG) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Equine Rabies Immunoglobulin (ERIG) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Equine Rabies Immunoglobulin (ERIG) by Region (2021-2026)
10.4 North America Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.5 Europe Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.6 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.7 Latin America Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Estimates and Projections (2021-2026)
11 RESEARCH FINDING AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Equine Rabies Immunoglobulin (ERIG) Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Equine Rabies Immunoglobulin (ERIG) Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Equine Rabies Immunoglobulin (ERIG) Players to Combat Covid-19 Impact
Table 9. Global Key Equine Rabies Immunoglobulin (ERIG) Manufacturers Covered in This Study
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2015-2020)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Equine Rabies Immunoglobulin (ERIG) Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Equine Rabies Immunoglobulin (ERIG) Sales Sites and Area Served
Table 16. Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Types
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Equine Rabies Immunoglobulin (ERIG) Players
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Region (2015-2020)
Table 22. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2015-2020)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) by Region (2015-2020)
Table 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2015-2020)
Table 25. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 26. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 27. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 29. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 30. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 31. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2015-2020)
Table 37. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 38. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 39. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Type (2015-2020)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2015-2020)
Table 47. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) by Type (2015-2020)
Table 48. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2015-2020)
Table 49. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Type (2015-2020)
Table 50. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Application (2015-2020)
Table 51. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2015-2020)
Table 52. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate by Application (2015-2020)
Table 53. Serum China Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 54. Serum China Description and Business Overview
Table 55. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Serum China Main Product
Table 57. Serum China Recent Development
Table 58. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 59. Lanzhou Institute of Biological Products Corporation Information
Table 60. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Lanzhou Institute of Biological Products Main Product
Table 62. Lanzhou Institute of Biological Products Recent Development
Table 63. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 64. Wuhan Institute of Biological Products Corporation Information
Table 65. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Wuhan Institute of Biological Products Main Product
Table 67. Wuhan Institute of Biological Products Recent Development
Table 68. Premium Serums Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 69. Premium Serums Corporation Information
Table 70. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Premium Serums Main Product
Table 72. Premium Serums Recent Development
Table 73. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 74. Haffkine Bio-Pharmaceutical Corporation Information
Table 75. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Haffkine Bio-Pharmaceutical Main Product
Table 77. Haffkine Bio-Pharmaceutical Recent Development
Table 78. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 79. Bharat Serums Corporation Information
Table 80. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Bharat Serums Main Product
Table 82. Bharat Serums Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 86. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Forecast by Type (2021-2026)
Table 91. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2021-2026)
Table 92. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) Forecast by Type (2021-2026)
Table 93. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 94. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Forecast by Application (2021-2026)
Table 95. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Forecast by Region (2021-2026)
Table 97. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Region (2021-2026)
Table 98. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 1. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. COVID-19 Impact Global Market: (Four Equine Rabies Immunoglobulin (ERIG) Market Size Forecast Scenarios)
Table 5. Opportunities and Trends for Equine Rabies Immunoglobulin (ERIG) Players in the COVID-19 Landscape
Table 6. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 7. Key Regions/Countries Measures against Covid-19 Impact
Table 8. Proposal for Equine Rabies Immunoglobulin (ERIG) Players to Combat Covid-19 Impact
Table 9. Global Key Equine Rabies Immunoglobulin (ERIG) Manufacturers Covered in This Study
Table 10. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Manufacturers (2015-2020)
Table 11. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers (2015-2020)
Table 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million USD) by Manufacturers (2015-2020)
Table 13. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2015-2020)
Table 14. Global Market Equine Rabies Immunoglobulin (ERIG) Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 15. Manufacturers Equine Rabies Immunoglobulin (ERIG) Sales Sites and Area Served
Table 16. Manufacturers Equine Rabies Immunoglobulin (ERIG) Product Types
Table 17. Global Equine Rabies Immunoglobulin (ERIG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 18. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2019)
Table 19.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 20. Main Points Interviewed from Key Equine Rabies Immunoglobulin (ERIG) Players
Table 21. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Region (2015-2020)
Table 22. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2015-2020)
Table 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) by Region (2015-2020)
Table 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2015-2020)
Table 25. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 26. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 27. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 28. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 29. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 30. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 31. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 32. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 33. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2015-2020) (K Units)
Table 34. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2015-2020)
Table 35. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2015-2020) (US$ Million)
Table 36. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2015-2020)
Table 37. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 38. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 39. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 40. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 41. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2015-2020) (K Units)
Table 42. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2015-2020)
Table 43. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2015-2020) (US$ Million)
Table 44. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2015-2020)
Table 45. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Type (2015-2020)
Table 46. Global Equine Rabies Immunoglobulin (ERIG) Sales Share by Type (2015-2020)
Table 47. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) by Type (2015-2020)
Table 48. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Type (2015-2020)
Table 49. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Unit) by Type (2015-2020)
Table 50. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) by Application (2015-2020)
Table 51. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2015-2020)
Table 52. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate by Application (2015-2020)
Table 53. Serum China Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 54. Serum China Description and Business Overview
Table 55. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Serum China Main Product
Table 57. Serum China Recent Development
Table 58. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 59. Lanzhou Institute of Biological Products Corporation Information
Table 60. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. Lanzhou Institute of Biological Products Main Product
Table 62. Lanzhou Institute of Biological Products Recent Development
Table 63. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 64. Wuhan Institute of Biological Products Corporation Information
Table 65. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Wuhan Institute of Biological Products Main Product
Table 67. Wuhan Institute of Biological Products Recent Development
Table 68. Premium Serums Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 69. Premium Serums Corporation Information
Table 70. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Premium Serums Main Product
Table 72. Premium Serums Recent Development
Table 73. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 74. Haffkine Bio-Pharmaceutical Corporation Information
Table 75. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Haffkine Bio-Pharmaceutical Main Product
Table 77. Haffkine Bio-Pharmaceutical Recent Development
Table 78. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Corporation Information
Table 79. Bharat Serums Corporation Information
Table 80. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. Bharat Serums Main Product
Table 82. Bharat Serums Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Equine Rabies Immunoglobulin (ERIG) Distributors List
Table 86. Equine Rabies Immunoglobulin (ERIG) Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Forecast by Type (2021-2026)
Table 91. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Type (2021-2026)
Table 92. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) Forecast by Type (2021-2026)
Table 93. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 94. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Forecast by Application (2021-2026)
Table 95. Global Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global Equine Rabies Immunoglobulin (ERIG) Sales (K Units) Forecast by Region (2021-2026)
Table 97. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share Forecast by Region (2021-2026)
Table 98. Global Equine Rabies Immunoglobulin (ERIG) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type: 2020 VS 2026
Figure 3. 1500IU Product Picture
Figure 4. 1000IU Product Picture
Figure 5. 400IU Product Picture
Figure 6. Other Product Picture
Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application: 2020 VS 2026
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Global Equine Rabies Immunoglobulin (ERIG) Market Size 2015-2026 (US$ Million)
Figure 11. Global Equine Rabies Immunoglobulin (ERIG) Sales Capacity (K Units) (2015-2026)
Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers in 2020
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Equine Rabies Immunoglobulin (ERIG) Revenue in 2019
Figure 16. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2015-2020)
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2019
Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2015-2020)
Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in 2019
Figure 21. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 22. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 23. U.S. Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 28. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 29. Germany Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2019
Figure 40. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in 2019
Figure 41. China Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 64. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 65. Mexico Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 73. Turkey Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2015-2020)
Figure 80. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type in 2019
Figure 81. Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Type (2015-2020)
Figure 82. Revenue Market Share of Equine Rabies Immunoglobulin (ERIG) by Type in 2019
Figure 83. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2015-2020)
Figure 85. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Application (2015-2020)
Figure 87. Global Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Application in 2020
Figure 88. Serum China Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Lanzhou Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Wuhan Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Premium Serums Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Haffkine Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bharat Serums Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Price Trend of Key Raw Materials
Figure 95. Manufacturing Cost Structure of Equine Rabies Immunoglobulin (ERIG)
Figure 96. Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
Figure 97. Equine Rabies Immunoglobulin (ERIG) Industrial Chain Analysis
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. North America Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 102. North America Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
Figure 1. Picture of Equine Rabies Immunoglobulin (ERIG)
Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type: 2020 VS 2026
Figure 3. 1500IU Product Picture
Figure 4. 1000IU Product Picture
Figure 5. 400IU Product Picture
Figure 6. Other Product Picture
Figure 7. Global Equine Rabies Immunoglobulin (ERIG) Consumption Market Share by Application: 2020 VS 2026
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Global Equine Rabies Immunoglobulin (ERIG) Market Size 2015-2026 (US$ Million)
Figure 11. Global Equine Rabies Immunoglobulin (ERIG) Sales Capacity (K Units) (2015-2026)
Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers in 2020
Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Equine Rabies Immunoglobulin (ERIG) Revenue in 2019
Figure 16. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2015-2020)
Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2019
Figure 19. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2015-2020)
Figure 20. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in 2019
Figure 21. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 22. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 23. U.S. Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 28. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 29. Germany Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region in 2019
Figure 40. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region in 2019
Figure 41. China Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 64. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 65. Mexico Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country in 2019
Figure 73. Turkey Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Equine Rabies Immunoglobulin (ERIG) Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2015-2020)
Figure 80. Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type in 2019
Figure 81. Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Type (2015-2020)
Figure 82. Revenue Market Share of Equine Rabies Immunoglobulin (ERIG) by Type in 2019
Figure 83. Global Equine Rabies Immunoglobulin (ERIG) Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2015-2020)
Figure 85. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Application (2015-2020)
Figure 87. Global Revenue Share of Equine Rabies Immunoglobulin (ERIG) by Application in 2020
Figure 88. Serum China Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Lanzhou Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Wuhan Institute of Biological Products Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Premium Serums Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Haffkine Bio-Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bharat Serums Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Price Trend of Key Raw Materials
Figure 95. Manufacturing Cost Structure of Equine Rabies Immunoglobulin (ERIG)
Figure 96. Manufacturing Process Analysis of Equine Rabies Immunoglobulin (ERIG)
Figure 97. Equine Rabies Immunoglobulin (ERIG) Industrial Chain Analysis
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. North America Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 102. North America Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
